StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.44+0.26 (+6.22%)

Close on Nov 13, 2026Market cap $110.06MP/E –Yield –

Lexaria Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lexaria Bioscience's profit margin for the twelve months ending May 31, 2026 was -3985.6%. For fiscal 2025 it was -1686.0%, against -1248.2% the year before. The highest annual figure on record is 1841.8% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Aug 31, 2025-1686.0%−437.7
FY2024Aug 31, 2024-1248.2%+1698.1
FY2023Aug 31, 2023-2946.4%−100.1
FY2022Aug 31, 2022-2846.3%−2289.1
FY2021Aug 31, 2021-557.2%+740.4
FY2020Aug 31, 2020-1297.6%−3139.3
FY2019Aug 31, 20191841.8%+318.5
FY2018Aug 31, 20181523.2%+4555.1
FY2017Aug 31, 2017-3031.9%+104.9
FY2016Aug 31, 2016-3136.8%+10353.0
FY2015Aug 31, 2015-13489.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ1 2026Feb 28, 2026-7249.9%−5779.9
Q4 FY2025CQ3 2025Aug 31, 2025-1549.3%+1051.6
Q3 FY2025CQ2 2025May 31, 2025-2177.6%−56.6
Q2 FY2025CQ1 2025Feb 28, 2025-1559.3%−1111.4
Q1 FY2025CQ4 2024Nov 30, 2024-1470.0%−690.4
Q4 FY2024CQ3 2024Aug 31, 2024-2600.9%+1430.5
Q3 FY2024CQ2 2024May 31, 2024-2121.1%+930.8
Q2 FY2024CQ1 2024Feb 29, 2024-448.0%+6034.6
Q1 FY2024CQ4 2023Nov 30, 2023-779.6%+1017.1
Q4 FY2023CQ3 2023Aug 31, 2023-4031.5%−2711.2
Q3 FY2023CQ2 2023May 31, 2023-3051.9%−662.2
Q2 FY2023CQ1 2023Feb 28, 2023-6482.6%−1830.8
Q1 FY2023CQ4 2022Nov 30, 2022-1796.6%+12563.3
Q4 FY2022CQ3 2022Aug 31, 2022-1320.3%+2477.5
Q3 FY2022CQ2 2022May 31, 2022-2389.7%−1131.9
Q2 FY2022CQ1 2022Feb 28, 2022-4651.8%−4856.6
Q1 FY2022CQ4 2021Nov 30, 2021-14359.9%−14119.7
Q4 FY2021CQ3 2021Aug 31, 2021-3797.7%−2418.8
Q3 FY2021CQ2 2021May 31, 2021-1257.8%+2560.3
Q2 FY2021CQ1 2021Feb 28, 2021204.8%+2861.3
Q1 FY2021CQ4 2020Nov 30, 2020-240.2%+8710.3
Q4 FY2020CQ3 2020Aug 31, 2020-1378.9%−7087.4
Q3 FY2020CQ2 2020May 31, 2020-3818.1%−1835.9
Q2 FY2020CQ1 2020Feb 29, 2020-2656.5%+4856.1
Q1 FY2020CQ4 2019Nov 30, 2019-8950.5%−5792.3
Q4 FY2019CQ3 2019Aug 31, 20195708.4%−6727.0
Q3 FY2019CQ2 2019May 31, 2019-1982.2%+458.3
Q2 FY2019CQ1 2019Feb 28, 2019-7512.6%−6711.0
Q1 FY2019CQ4 2018Nov 30, 2018-3158.1%−809.0
Q4 FY2018CQ3 2018Aug 31, 201812435.4%+18167.1
Q3 FY2018CQ2 2018May 31, 2018-2440.4%–
Q2 FY2018CQ1 2018Feb 28, 2018-801.6%–
Q1 FY2018CQ4 2017Nov 30, 2017-2349.1%–
Q4 FY2017CQ3 2017Aug 31, 2017-5731.7%–

More Lexaria Bioscience figures

See a number that looks wrong?